Needham & Company LLC Begins Coverage on Ocular Therapeutix (NASDAQ:OCUL)
Analysts at Needham & Company LLC initiated coverage on shares of Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) in a report issued on Tuesday, Marketbeat reports. The brokerage set a “buy” rating and a $15.00 price target on the biopharmaceutical company’s stock. Needham & Company LLC’s price objective indicates a potential upside of 77.94% from […]
Analysts at Needham & Company LLC initiated coverage on shares of Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) in a report issued on Tuesday, Marketbeat reports. The brokerage set a “buy” rating and a $15.00 price target on the biopharmaceutical company’s stock. Needham & Company LLC’s price objective indicates a potential upside of 77.94% from […]
